Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC 632 Measure Title Measure Source Coronary Artery Bypass Graft (CABG): Anti-platelet Medications at Discharge + STS Coronary Artery Bypass Graft (CABG): Beta Blockade at Discharge + STS Coronary Artery Bypass Graft (CABG): Lipid Management and Counseling + STS Hemodialysis Vascular Access Decision-making by Surgeons to Maximize Placement of Society for Vascular Autogenous Arterial Venous Fistula Surgeons (SVS) + This measure is reportable only via registry-based reporting and is not reportable via claims-based reporting. As previously mentioned in this final rule, we are not finalizing the proposed measure, Use of Imaging Studies in Low Back Pain, in the final 2009 PQRI quality measures set listed in Table 16 based on comments received. In addition, we are not finalizing the following proposed NQF-endorsed measure in the final 2009 PQRI measures because its adaptation to the PQRI format was subsequently found to be not feasible: Selection of Antibiotic Administration for Cardiac Surgery Patients. Substantive components of this measure are duplicative of Measure # 21 Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation Cephalosporin, which is listed in Table 15. As stated above, there are 8 measures listed in Table 16 that can be reported only via a registry for the 2009 PQRI and, therefore, are not reportable via claims- based reporting. As described in the CY 2009 PFS proposed rule (73 FR 38570), measures designated as T### in the proposed
CMS-1403-FC rule indicated that the measure was included in the 2008 Measure Testing Process. The T#### identifier was removed from Table 16 in this final rule with comment because each measure in the final 2009 PQRI quality measures set will be assigned a unique number which may be obtained from the detailed specifications which will be made available on the PQRI section of the CMS Web site no later than December 31, 2008. iii. Additional AQA Adopted Measures As discussed in the CY 2009 PFS proposed rule (73 FR 38565 through 38566), in circumstances where no NQF-endorsed measure is available, a quality measure that has been adopted by the AQA would also meet the requirements of section 1848(k)(2)(B)(i) of the Act. As such, we proposed 21 new measures adopted by the AQA that had not yet been reviewed or endorsed by the NQF at the time the CY 2009 PFS proposed rule was published and that were not included in the final set of 2008 PQRI quality measures (73 FR 38571). We received numerous comments on the 21 proposed additional AQA-adopted measures, which are summarized and addressed below. 633
- Page 581 and 582: CMS-1403-FC ● Agree that the regi
- Page 583 and 584: CMS-1403-FC soon thereafter as is t
- Page 585 and 586: CMS-1403-FC Comment: We received ma
- Page 587 and 588: CMS-1403-FC Comment: One commenter
- Page 589 and 590: CMS-1403-FC additional 2.0 percent
- Page 591 and 592: CMS-1403-FC EHRs in 2009. The measu
- Page 593 and 594: CMS-1403-FC i. Overview and Summary
- Page 595 and 596: CMS-1403-FC voluntary consensus sta
- Page 597 and 598: CMS-1403-FC Comment: Several commen
- Page 599 and 600: CMS-1403-FC the AMA-PCPI should be
- Page 601 and 602: CMS-1403-FC are appropriate and do
- Page 603 and 604: CMS-1403-FC to make any changes to
- Page 605 and 606: CMS-1403-FC post the measures for p
- Page 607 and 608: CMS-1403-FC beneficiaries. We now h
- Page 609 and 610: CMS-1403-FC identified in Tables 15
- Page 611 and 612: CMS-1403-FC important difference in
- Page 613 and 614: CMS-1403-FC not use Measures #73 Ca
- Page 615 and 616: CMS-1403-FC measures, but which are
- Page 617 and 618: CMS-1403-FC with comment period. Ho
- Page 619 and 620: CMS-1403-FC ● Measure #41 Osteopo
- Page 621 and 622: CMS-1403-FC professional to simply
- Page 623 and 624: CMS-1403-FC measures. We consider t
- Page 625 and 626: CMS-1403-FC Measure Number and Titl
- Page 627 and 628: CMS-1403-FC Measure Number and Titl
- Page 629 and 630: CMS-1403-FC ● Measure #120 CKD: A
- Page 631: CMS-1403-FC For the 2009 PQRI quali
- Page 635 and 636: CMS-1403-FC Response: As suggested
- Page 637 and 638: CMS-1403-FC required for the measur
- Page 639 and 640: CMS-1403-FC ● Achievement of NQF
- Page 641 and 642: CMS-1403-FC These additional measur
- Page 643 and 644: CMS-1403-FC We did not include this
- Page 645 and 646: CMS-1403-FC Comment: Many commenter
- Page 647 and 648: CMS-1403-FC groups must have a part
- Page 649 and 650: CMS-1403-FC selected for inclusion
- Page 651 and 652: CMS-1403-FC Measure Title Measure S
- Page 653 and 654: CMS-1403-FC proposed HIV/AIDS measu
- Page 655 and 656: CMS-1403-FC set of denominator spec
- Page 657 and 658: CMS-1403-FC results, for this purpo
- Page 659 and 660: CMS-1403-FC informed decision-makin
- Page 661 and 662: CMS-1403-FC Comment: Several commen
- Page 663 and 664: CMS-1403-FC prior commitments that
- Page 665 and 666: CMS-1403-FC groups who successfully
- Page 667 and 668: CMS-1403-FC ● Eligible profession
- Page 669 and 670: CMS-1403-FC patients, families, and
- Page 671 and 672: CMS-1403-FC that have satisfactoril
- Page 673 and 674: CMS-1403-FC e-prescribing quality m
- Page 675 and 676: CMS-1403-FC Douglas S. and Friedman
- Page 677 and 678: CMS-1403-FC subsequent year, if the
- Page 679 and 680: CMS-1403-FC eligible professional f
- Page 681 and 682: CMS-1403-FC and is included in the
<strong>CMS</strong>-1403-FC<br />
632<br />
Measure Title Measure Source<br />
Coronary Artery Bypass Graft (CABG): Anti-platelet Medications at Discharge + STS<br />
Coronary Artery Bypass Graft (CABG): Beta Blockade at Discharge + STS<br />
Coronary Artery Bypass Graft (CABG): Lipid Management and Counseling + STS<br />
Hemodialysis Vascular Access Decision-making by Surgeons to Maximize Placement of Society for Vascular<br />
Autogenous Arterial Venous Fistula<br />
Surgeons (SVS)<br />
+<br />
<strong>This</strong> measure is reportable only via registry-based reporting and is not reportable via claims-based<br />
reporting.<br />
As previously mentioned in this final rule, we are not<br />
finalizing the proposed measure, Use of Imaging Studies in<br />
Low Back Pain, in the final 2009 PQRI quality measures set<br />
listed in Table 16 based on comments received.<br />
In addition, we are not finalizing the following<br />
proposed NQF-endorsed measure in the final 2009 PQRI<br />
measures because its adaptation to the PQRI format was<br />
subsequently found to be not feasible: Selection of<br />
Antibiotic Administration for Cardiac Surgery Patients.<br />
Substantive components of this measure are duplicative of<br />
Measure # 21 Perioperative Care: Selection of Prophylactic<br />
Antibiotic - First OR Second Generation Cephalosporin,<br />
which is listed in Table 15.<br />
As stated above, there are 8 measures listed in<br />
Table 16 that can be reported only via a registry for the<br />
2009 PQRI and, therefore, are not reportable via claims-<br />
based reporting.<br />
As described in the CY 2009 PFS proposed rule<br />
(73 FR 38570), measures designated as T### in the proposed